Ro5
Ro5 is a company dedicated to accelerating drug discovery and clinical trial processes through advanced AI, data science, and analytics. They develop AI platforms and provide professional services to pharma, biotech, and academic institutions, with a focus on de novo drug discovery, bioactivity, ADMET, and knowledge graph capabilities. Their mission is to address the urgent need for faster disease treatment solutions.
Industries
Nr. of Employees
small (1-50)
Patents
System and method for molecular reconstruction from molecular probability distributions
US-12223435-B2
View DetailsSystem and method for the latent space optimization of generative machine learning models
US-11610139-B2
View DetailsSystem and method for accelerating FEP methods using a 3D-restricted variational autoencoder
US-11568961-B2
View Details
System and method for molecular reconstruction from molecular probability distributions
US-12223435-B2
View DetailsSystem and method for the latent space optimization of generative machine learning models
US-11610139-B2
View DetailsSystem and method for accelerating FEP methods using a 3D-restricted variational autoencoder
US-11568961-B2
View DetailsProducts
AI platforms for molecular analytics and structure-based screening
Web-deployed platforms that perform molecular representation, structure-based screening, bioactivity prediction, and data integration through knowledge-graph workspaces to support discovery and prospective experimental validation.
AI platforms for molecular analytics and structure-based screening
Web-deployed platforms that perform molecular representation, structure-based screening, bioactivity prediction, and data integration through knowledge-graph workspaces to support discovery and prospective experimental validation.
Services
Tailored consulting and delivery of AI-enabled tools and workflows to support drug discovery stages and clinical-trial analytics; services can be individual tools or comprehensive end-to-end programs delivered by in-house scientists.
Tailored consulting and delivery of AI-enabled tools and workflows to support drug discovery stages and clinical-trial analytics; services can be individual tools or comprehensive end-to-end programs delivered by in-house scientists.
Expertise Areas
- De novo drug discovery
- Bioactivity and protein–ligand prediction
- ADMET modeling
- Knowledge graph–enabled data integration
Key Technologies
- Knowledge graphs
- Structure-based deep learning
- Point-cloud machine learning for molecular data
- 3D variational / conditional generative adversarial networks
News & Updates
Announcement of the release of the SpectraView v1 web application.
Announcement of the HydraScreen web application in support of the preprint.
Introduction of HydraScreen, an advanced tool for drug discovery.
A study combining SpectraView with other methods for faster hit identification.
Discussion of future lab technology involving software vendors and pharma companies.
Ro5 used HydraScreen to screen compounds and compare performance.
Announcement of the release of the SpectraView v1 web application.
Announcement of the HydraScreen web application in support of the preprint.
Introduction of HydraScreen, an advanced tool for drug discovery.
A study combining SpectraView with other methods for faster hit identification.
Discussion of future lab technology involving software vendors and pharma companies.
Ro5 used HydraScreen to screen compounds and compare performance.